Genetic testing to identify women at risk of venous thromboembolism with contraceptive pills: Evidence or hope-based tool ?


Combined oestrogen-progestin oral contraceptives cause venous thromboembolism in women of reproductive age. Healthcare providers typically rely on women’s characteristics, medical history and family history to select the most appropriate contraceptives, in an effort to reduce risks of venous thromboembolism. This position paper discusses the use of a new… (More)
DOI: 10.4414/smw.2016.14321


Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.

Slides referencing similar topics